Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05307874 |
| Title | Phase 1/2a Study of ICT01 Plus Low Dose SC IL-2 in Patients With Advanced Solid Tumors (EVICTION-2) |
| Acronym | EVICTION-2 |
| Recruitment | Active, not recruiting |
| Gender | |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | ImCheck Therapeutics |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | GBR | FRA | DEU |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Institute Gustave Roussy | Paris | France | Details | |||
| IUCT Oncopole Claudius Regaud | Toulouse | France | Details | |||
| University Carl Gustav Carus | Dresden | Germany | Details | |||
| Universitätsklinikum Wuerzburg | Würzburg | Germany | Details | |||
| The Institute of Cancer Research | Sutton | United Kingdom | Details |